Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems
Authors
Keywords
-
Journal
JOURNAL OF NEUROENDOCRINOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-12-24
DOI
10.1111/jne.13226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P701. Association of SSRI Medications and Menstrual Cycle Phase With Neuroactive Steroid Levels in a Transdiagnostic Outpatient Sample With Suicidality
- (2022) Jordan Barone et al. BIOLOGICAL PSYCHIATRY
- Neurosteroids and Neurotrophic Factors: What Is Their Promise as Biomarkers for Major Depression and PTSD?
- (2021) Felipe Borges Almeida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Substance use, mental disorders and COVID-19
- (2021) Christina Marel et al. CURRENT OPINION IN PSYCHIATRY
- Endocannabinoids and Precision Medicine for Mood Disorders and Suicide
- (2021) Graziano Pinna Frontiers in Psychiatry
- Neuroactive Steroids and Depression in Early Pregnancy
- (2021) Elizabeth S Wenzel et al. PSYCHONEUROENDOCRINOLOGY
- Effect of Zuranolone vs Placebo in Postpartum Depression
- (2021) Kristina M. Deligiannidis et al. JAMA Psychiatry
- PPAR-α Hypermethylation in the Hippocampus of Mice Exposed to Social Isolation Stress Is Associated with Enhanced Neuroinflammation and Aggressive Behavior
- (2021) Francesco Matrisciano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inflammatory Biomarkers for Mood Disorders - A Brief Narrative Review
- (2020) Hui H. Chang et al. CURRENT PHARMACEUTICAL DESIGN
- An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
- (2020) Marika Cordaro et al. Antioxidants
- Allopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?
- (2020) Graziano Pinna Frontiers in Endocrinology
- The impact of the COVID-19 pandemic on suicide rates
- (2020) Leo Sher QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective
- (2020) Steven M Paul et al. Neurobiology of Stress
- Allopregnanolone (1938-2019): A trajectory of 80 years of outstanding scientific achievments
- (2020) Graziano Pinna Neurobiology of Stress
- Circuit-Based Biomarkers for Mood and Anxiety Disorders
- (2020) Frances Xia et al. TRENDS IN NEUROSCIENCES
- Activation of PPAR-α by N-palmitoylethanolamine engages allopregnanolone biosynthesis to modulate emotional behavior
- (2019) Andrea Locci et al. BIOLOGICAL PSYCHIATRY
- Animal models of post-traumatic stress disorder and novel treatment targets
- (2019) Dario Aspesi et al. BEHAVIOURAL PHARMACOLOGY
- Current understanding of fear learning and memory in humans and animal models and the value of a linguistic approach for analyzing fear learning and memory in humans
- (2019) Jacob Raber et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Animal Models of PTSD: The Socially Isolated Mouse and the Biomarker Role of Allopregnanolone
- (2019) Graziano Pinna Frontiers in Behavioral Neuroscience
- Trial of SAGE-217 in Patients with Major Depressive Disorder
- (2019) Handan Gunduz-Bruce et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and the dimensions of depression: A review
- (2019) Marzieh Majd et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Efficacy of melatonin as an adjunct in the treatment of acute mania
- (2019) Hossein Sanjari Moghaddam et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Inflammation in psychiatric disorders: what comes first?
- (2018) Moisés E. Bauer et al. Annals of the New York Academy of Sciences
- Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial
- (2018) Maryam Ghazizadeh-Hashemi et al. JOURNAL OF AFFECTIVE DISORDERS
- Could a blood test for PTSD and depression be on the horizon?
- (2018) Dario Aspesi et al. Expert Review of Proteomics
- Protein biomarkers of mood disorders
- (2017) Carmen Rodríguez Cerdeira et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum
- (2017) Laura E Dichtel et al. NEUROPSYCHOPHARMACOLOGY
- The interface of depression and obesity
- (2017) Nattinee Jantaratnotai et al. Obesity Research & Clinical Practice
- WY-14643, a selective agonist of peroxisome proliferator-activated receptor-α, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in mice
- (2017) Rongrong Yang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study
- (2017) Lauren M. Osborne et al. PSYCHONEUROENDOCRINOLOGY
- Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment
- (2017) Andrea Locci et al. Frontiers in Cellular Neuroscience
- The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
- (2016) Stefania Petrosino et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoid concentrations in hair are associated with PTSD symptom severity
- (2016) Sarah Wilker et al. PSYCHONEUROENDOCRINOLOGY
- Consequences of Misdiagnosis
- (2015) Henry A. Nasrallah JOURNAL OF CLINICAL PSYCHIATRY
- Free and Easy Wanderer Plus (FEWP) improves behavioral deficits in an animal model of post-traumatic stress disorder by stimulating allopregnanolone biosynthesis
- (2015) Zhi-Kun Qiu et al. NEUROSCIENCE LETTERS
- Short communication - N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice
- (2014) Hai-Ling Yu et al. Pharmacological Reports
- Palmitoylethanolamide in CNS health and disease
- (2014) Giuseppina Mattace Raso et al. PHARMACOLOGICAL RESEARCH
- Effects of Palmitoylethanolamide and Luteolin in an Animal Model of Anxiety/Depression
- (2013) Rosalia Crupi et al. CNS & Neurological Disorders-Drug Targets
- The role of allopregnanolone in depression and anxiety
- (2013) Cornelius Schüle et al. PROGRESS IN NEUROBIOLOGY
- The Endocannabinoid System and its Role in Schizophrenia: A Systematic Review of the Literature
- (2013) Rodrigo Ferretjans et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Immunity, Inflammation, and Bipolar Disorder: Diagnostic and Therapeutic Implications
- (2013) Nora Hamdani et al. Current Psychiatry Reports
- SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake
- (2009) Graziano Pinna et al. CURRENT OPINION IN PHARMACOLOGY
- GABAAR Plasticity during Pregnancy: Relevance to Postpartum Depression
- (2008) Jamie Maguire et al. NEURON
- Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder
- (2008) F. Pibiri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now